Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis
- PMID: 36522728
- DOI: 10.1111/bju.15950
Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis
Abstract
Objectives: To investigate the prevalence of prostate cancer in men attending evaluation for haematuria, as this could help healthcare providers to determine whether men with haematuria should have prostate examinations performed.
Methods: The study was performed according to a pre-specified protocol uploaded to the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022299383). A systematic search of MEDLINE, Ovid and Google Scholar was performed in December 2021. Two independent researchers evaluated all titles, available abstracts, and full texts. We included studies on adult men (aged ≥18 years) describing haematuria and prostate cancer.
Results: We screened 4252 titles and abstracts when available and assessed 350 studies in full text. In total, 65 studies were included and 42 was summarised in a meta-analysis. In total, 18 752 men with haematuria were included, and the pooled prevalence (95% confidence interval [CI]) of prostate cancer was 3.0% (2.0-4.1%). In men with macroscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 5.9% (2.9-9.9%; n = 265/5373). In men with microscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 1.4% (0.8-2.2%; n = 71/6642).
Conclusion: Our findings indicate that the prevalence of prostate cancer is considerable in men attending evaluation for haematuria. Therefore, digital rectal examination and prostate-specific antigen measurement should become a standard procedure for all men with haematuria, especially for men with macroscopic haematuria.
Keywords: #PCSM; #ProstateCancer; #uroonc; haematuria; macroscopic haematuria; meta-analysis; microscopic haematuria; prostate cancer; systematic review.
© 2022 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
References
-
- Bruyninckx R, Buntinx F, Aertgeerts B, Van Casteren V. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract 2003; 53: 31-5
-
- Bolenz C, Schroppel B, Eisenhardt A, Schmitz-Drager BJ, Grimm MO. The investigation of hematuria. Dtsch Arztebl Int 2018; 115: 801-7
-
- Davis R, Jones JS, Barocas DA et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 2012; 188: 2473-81
-
- Woldu SL, Ng CK, Loo RK et al. Evaluation of the new American urological association guidelines risk classification for hematuria. J Urol 2021; 205: 1387-93
-
- Ingelfinger JR. Hematuria in Adults. N Engl J Med 2021; 385: 153-63
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
